Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Cardiovascular Prevention Guidelines
Clin Investig Arterioscler. 2021 Mar-Apr;33(2):85-107.
doi: 10.1016/j.arteri.2020.11.004.
Epub 2021 Jan 22.
[Article in
English,
Spanish]
Authors
Pedro Armario
1
, Carlos Brotons
2
, Roberto Elosua
3
, Maria Alonso de Leciñana
4
, Almudena Castro
5
, Albert Clarà
6
, Olga Cortés
7
, Ángel Díaz Rodriguez
8
, María Herranz
9
, Soledad Justo
10
, Carlos Lahoz
11
, Juan Pedro-Botet
12
, Antonio Pérez Pérez
13
, Rafael Santamaria
14
, Ricard Tresserras
15
, Susana Aznar Lain
16
, Miguel Ángel Royo-Bordonada
17
Affiliations
- 1 Sociedad Española-Liga Española para la Lucha contra la Hipertensión Arterial, Madrid, España. Electronic address: [email protected].
- 2 Sociedad Española de Medicina de Familia y Comunitaria, Barcelona, España.
- 3 Sociedad Española de Epidemiología, Barcelona, España.
- 4 Sociedad Española de Neurología, España.
- 5 Sociedad Española de Cardiología-Coordinadora Nacional Sección de Prevención, Madrid, España.
- 6 Sociedad Española de Angiología y Cirugía Vascular, Madrid, España.
- 7 Asociación Española Pediatría de Atención Primaria, Madrid, España.
- 8 Sociedad Española de Médicos de Atención Primaria-Semergen, Madrid, España.
- 9 Federación de Asociaciones de Enfermería Comunitaria y Atención Primaria-FAECAP, Madrid, España.
- 10 Ministerio de Sanidad, Madrid, España.
- 11 Sociedad Española de Medicina Interna, Madrid, España.
- 12 Sociedad Española de Arteriosclerosis, Barcelona, España.
- 13 Sociedad Española de Diabetes, Madrid, España.
- 14 Sociedad Española de Nefrología, España.
- 15 Sociedad Española de Salud Pública y Administración Sanitaria-SESPAS, Barcelona, España.
- 16 Facultad de Ciencias del Deporte, Universidad Castilla La Mancha, Toledo, España.
- 17 Instituto de Salud Carlos III, Madrid, España.
Abstract
We present the adaptation for Spain of the updated European Cardiovascular Prevention Guidelines. In this update, greater stress is laid on the population approach, and especially on the promotion of physical activity and healthy diet through dietary, leisure and active transport policies in Spain. To estimate vascular risk, note should be made of the importance of recalibrating the tables used, by adapting them to population shifts in the prevalence of risk factors and incidence of vascular diseases, with particular attention to the role of chronic kidney disease. At an individual level, the key element is personalised support for changes in behaviour, adherence to medication in high-risk individuals and patients with vascular disease, the fostering of physical activity, and cessation of smoking habit. Furthermore, recent clinical trials with PCSK9 inhibitors are reviewed, along with the need to simplify pharmacological treatment of arterial hypertension to improve control and adherence to treatment. In the case of patients with type 2 diabetes mellitus and vascular disease or high vascular disease risk, when lifestyle changes and metformin are inadequate, the use of drugs with proven vascular benefit should be prioritised. Lastly, guidelines on peripheral arterial disease and other specific diseases are included, as is a recommendation against prescribing antiaggregants in primary prevention.
Keywords:
Arterial hypertension; Clinical Practice Guidelines; Control de lípidos; Diabetes; Dieta saludable; Enfermedades vasculares; Guías de Práctica Clínicas; Healthy diet; Hipertensión arterial; Lipid control; Prevención y control; Prevention and control; Smoking; Tabaco; Vascular diseases.
Copyright © 2020 Sociedad Española de Arteriosclerosis. Publicado por Elsevier España, S.L.U. All rights reserved.
MeSH terms
-
Cardiovascular Diseases / etiology
-
Cardiovascular Diseases / prevention & control*
-
Diet
-
Exercise
-
Health Promotion
-
Heart Disease Risk Factors
-
Humans
-
Life Style*
-
Medication Adherence
-
Practice Guidelines as Topic*
-
Smoking Cessation
-
Spain